Expression and function of fatty acid amide hydrolase in prostate cancer

被引:77
|
作者
Endsley, Michael P. [1 ]
Thill, Rebecca [1 ]
Choudhry, Iffat [2 ]
Williams, Carol L. [1 ]
Kajdacsy-Balla, Andre [2 ]
Campbell, William B. [1 ]
Nithipatikom, Kasem [1 ]
机构
[1] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA
[2] Univ Illinois, Dept Pathol, Chicago, IL USA
关键词
fatty acid amide hydrolase; 2-arachidonoylglycerol; cell invasion; prostate cancer; endocannabinoid;
D O I
10.1002/ijc.23674
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The hydrolysis of endocannabinoids has profound effects on the function of the endocannabinoid signaling system in the regulation of prostate carcinoma cells. Prostate carcinoma cells exhibit a wide range of hydrolysis activity for 2-arachidonoylglycerol (2-AG), the major endocannabinoid. However, enzyme(s) responsible for 2-AG hydrolysis and their functions in prostate cancer have not been characterized. In this study, we demonstrated that fatty acid amide hydrolase (FAAH) was differentially expressed in normal and prostate carcinoma cells. In PC-3 cells, overexpression of FAAH resulted in increased FAAH protein, 2-AG hydrolysis, cell invasion and cell migration. Conversely, small-interfering RNA (siRNA) knockdown of FAAH in LNCaP cells decreased FAAH protein, 2-AG hydrolysis and cell invasion. Furthermore, CAY10401, a FAAH inhibitor, decreased cell invasion and it enhanced the reduction of invasion in FAAH siRNA-transfected LNCaP cells. Immunohistochemistry staining of commercial tissue microarrays (TMAs) demonstrated FAAH staining in 109 of 157 cores of prostate adenocarcinomas but weak staining in I of 8 cores of normal prostate tissues. These results suggest that FAAH regulates 2-AG hydrolysis and invasion of prostate carcinoma cells and is potentially involved in prostate tumorigenesis. (C) 2008 Wiley-Liss. Inc.
引用
收藏
页码:1318 / 1326
页数:9
相关论文
共 50 条
  • [1] The expression and functions of fatty acid amide hydrolase in prostate cancer
    Endsley, Michael Patrick
    Isbell, Marilyn A.
    Choudhry, Iffat
    Kajdacsy-Balla, Andre
    Campbell, William B.
    Nithipatikom, Kasem
    FASEB JOURNAL, 2007, 21 (05): : A421 - A421
  • [2] Structure and function of fatty acid amide hydrolase
    McKinney, MK
    Cravatt, BF
    ANNUAL REVIEW OF BIOCHEMISTRY, 2005, 74 : 411 - 432
  • [3] Computational insights into function and inhibition of fatty acid amide hydrolase
    Palermo, Giulia
    Rothlisberger, Ursula
    Cavalli, Andrea
    De Vivo, Marco
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2015, 91 : 15 - 26
  • [4] The fatty acid amide hydrolase (FAAH)
    Ueda, N
    Puffenbarger, RA
    Yamamoto, S
    Deutsch, DG
    CHEMISTRY AND PHYSICS OF LIPIDS, 2000, 108 (1-2) : 107 - 121
  • [5] The fatty acid amide hydrolase (FAAH)
    Deutsch, DG
    Ueda, N
    Yamamoto, S
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2002, 66 (2-3): : 201 - 210
  • [6] Involvement of Fatty Acid Amide Hydrolase and Fatty Acid Binding Protein 5 in the Uptake of Anandamide by Cell Lines with Different Levels of Fatty Acid Amide Hydrolase Expression: A Pharmacological Study
    Bjorklund, Emmelie
    Blomqvist, Anders
    Hedlin, Joel
    Persson, Emma
    Fowler, Christopher J.
    PLOS ONE, 2014, 9 (07):
  • [7] Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer
    Isabel Tundidor
    Marta Seijo-Vila
    Sandra Blasco-Benito
    María Rubert-Hernández
    Sandra Adámez
    Clara Andradas
    Sara Manzano
    Isabel Álvarez-López
    Cristina Sarasqueta
    María Villa-Morales
    Carmen González-Lois
    Esther Ramírez-Medina
    Belén Almoguera
    Antonio J. Sánchez-López
    Laura Bindila
    Sigrid Hamann
    Norbert Arnold
    Christoph Röcken
    Ignacio Heras-Murillo
    David Sancho
    Gema Moreno-Bueno
    María M. Caffarel
    Manuel Guzmán
    Cristina Sánchez
    Eduardo Pérez-Gómez
    Nature Communications, 14
  • [8] Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer
    Tundidor, Isabel
    Seijo-Vila, Marta
    Blasco-Benito, Sandra
    Rubert-Hernandez, Maria
    Adamez, Sandra
    Andradas, Clara
    Manzano, Sara
    Alvarez-Lopez, Isabel
    Sarasqueta, Cristina
    Villa-Morales, Maria
    Gonzalez-Lois, Carmen
    Ramirez-Medina, Esther
    Almoguera, Belen
    Sanchez-Lopez, Antonio J.
    Bindila, Laura
    Hamann, Sigrid
    Arnold, Norbert
    Roecken, Christoph
    Heras-Murillo, Ignacio
    Sancho, David
    Moreno-Bueno, Gema
    Caffarel, Maria M.
    Guzman, Manuel
    Sanchez, Cristina
    Perez-Gomez, Eduardo
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [9] Fatty acid amide hydrolase as a target for neuroprotection
    Graves, R. S.
    Pryce, G.
    Cabranes, A.
    Fernandez-Ruiz, J.
    Bisogno, T.
    Di Marzo, V.
    Cravatt, B. F.
    Michael, G. J.
    Giovannoni, G.
    Elphick, M. R.
    Baker, D.
    MULTIPLE SCLEROSIS JOURNAL, 2011, 17 : S431 - S431
  • [10] Anandamide amidohydrolase (fatty acid amide hydrolase)
    Ueda, N
    Yamamoto, S
    PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2000, 61 (1-2): : 19 - 28